evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/geneAliases/10,gene/geneAliases/11,gene/geneAliases/12,gene/geneAliases/13,gene/geneAliases/14,gene/geneAliases/15,gene/geneAliases/16,gene/geneAliases/17,gene/geneAliases/18,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract
18370,GENE_SUMMARY,,"TP63 encodes a transcription factor involved in organ development. Overexpression and amplifications of TP63 are found in squamous cell carcinomas of the head and neck, among other cancers.",,2017-03-01,,8626,TP63,tumor protein p63,False,ENST00000264731,NM_003722.4,OFC8,AIS,SHFM4,p63,B(p51B),p40,p51,B(p51A),p73H,EEC3,TP53CP,TP73L,LMS,p73L,TP53L,p53CP,KET,RHS,NBP,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18371,GENE_BACKGROUND,,"In mammals, the p53 family comprises twoadditional members, p63 and p73 (hereafter referred toas TP53, TP63, and TP73, respectively). The usageof two alternative promoters produces protein variantseither with (transactivating [TA] isoforms) or without(N isoforms) the N-terminal transactivation domain(TAD). In general, the TA proteins exert TP53-liketumor-suppressive activities through their ability to ac-tivate a common set of target genes. The N proteinscan act as dominant-negative inhibitors of the transcrip-tionally active family members. Additionally, they possessintrinsic-specific biological activities due to the presenceof alternative TADs, and as a result of engaging a different(PMID: 24488880) (PMID: 23165243) (PMID: 21515338) (PMID: 17334395) (PMID: 17426453) (PMID: 25085956) TP63 (Tumor protein 63) is an evolutionarly older homologue of the TP53 tumor suppressor. The TP53 family of transcription factors comprises of TP53, TP63 and TP73. All members share the same structure including an amino-terminal transactivation domain (TAD), a DNA-binding domain (DBD), and a carboxyterminal oligomerization domain (OD) (PMID: 20484388). TP63 exists in two protein variants either with the N-terminal transactivation domain (TAD) (=transactivating isoform) or without (N isoform) (PMID: 16601753). The transactivating isoform (TA) of TP63 exerts TP53-like tumor-suppressive activities through its ability to activate a common set of target genes (PMID: 16601753). The N isoform on the other hand can act as dominant-negative inhibitor of the transcriptionally active family members (PMID: 16601753). TP63 can therefore exhibit oncogenic as well as tumor suppressor functions depending on the isotype expressed.TP63 exhibits a unique role in the regulation of epithelial morphogenesis and epithelial stem cell maintenance and differentiation (PMID: 10227293, 10227294).TP63 has been shown to be involved in tumorigenesis and cancer progression including inhibition of cancer metastasis(PMID: 21760596). TP63 is rarely mutated in cancer, however, it is found overexpressed and amplified in various carcinomas such as squamous cell carcinoma of the head and neck (PMID: 17264681). Regulation of cell adhesion and tissue integrity may affect tumor metastasis and invasion (PMID: 20962848). Immunohistochemistry of TP63 is widely used for the diagnosis of poorly differentiated carcinoma and can help distinguish malign and benign prostatic gland tissue (PMID: 24488880, 23165243, 21515338, 17334395, 17426453, 25085956).",,2017-03-01,,8626,TP63,tumor protein p63,False,ENST00000264731,NM_003722.4,OFC8,AIS,SHFM4,p63,B(p51B),p40,p51,B(p51A),p73H,EEC3,TP53CP,TP73L,LMS,p73L,TP53L,p53CP,KET,RHS,NBP,False,23165243,p63 the guardian of human reproduction.,"Cell cycle (Georgetown, Tex.)",2017-12-15T20:12:00,11,24,4545-51,Amelio I et al,doi: 10.4161/cc.22819,,0001-12-15,,17426453,p63: the phantom of the tumor suppressor.,"Cell cycle (Georgetown, Tex.)",2018-05-02T20:07:00,6,9,1062-71,Finlan LE et al,,,0001-05-02,,16601753,p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.,Cell death and differentiation,2018-06-01T20:06:00,13,6,962-72,Murray-Zmijewski F et al,,,0001-06-01,,10227293,p63 is a p53 homologue required for limb and epidermal morphogenesis.,Nature,0001-04-22,398,6729,708-13,Mills AA et al,,,0001-04-22,,24488880,How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors.,Human mutation,2018-06-01T20:14:00,35,6,702-14,Candi E et al,doi: 10.1002/humu.22523,,0001-06-01,,20484388,"p63 and p73, the ancestors of p53.",Cold Spring Harbor perspectives in biology,2018-09-01T20:10:00,2,9,a004887,Dötsch V et al,doi: 10.1101/cshperspect.a004887,,0001-09-01,,21515338,Role of p63 in cancer development.,Biochimica et biophysica acta,2018-08-01T20:11:00,1816,True,57-66,Graziano V et al,doi: 10.1016/j.bbcan.2011.04.002,,0001-08-01,,10227294,"p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.",Nature,0001-04-22,398,6729,714-8,Yang A et al,,,0001-04-22,,25085956,p53/p63/p73 in the epidermis in health and disease.,Cold Spring Harbor perspectives in medicine,2018-08-01T20:14:00,4,8,,Botchkarev VA et al,pii: a015248. doi: 10.1101/cshperspect.a015248,,0001-08-01,,20962848,TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.,Nature,2018-10-21T20:10:00,467,7318,986-90,Su X et al,doi: 10.1038/nature09459,,0001-10-21,,21760596,p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.,Cell death and differentiation,2018-09-01T20:11:00,18,9,1487-99,Melino G,doi: 10.1038/cdd.2011.81,,0001-09-01,,17334395,p63 and p73 in human cancer: defining the network.,Oncogene,2018-08-09T20:07:00,26,36,5169-83,Deyoung MP et al,,,0001-08-09,,17264681,TAp63 and DeltaNp63 in cancer and epidermal development.,"Cell cycle (Georgetown, Tex.)",2018-02-01T20:07:00,6,3,274-85,Candi E et al,,,0001-02-01,
